Spots Global Cancer Trial Database for neoadjuvant chemoradiotherapy
Every month we try and update this database with for neoadjuvant chemoradiotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy | NCT04815694 | Neoadjuvant Che... Locally Advance... Pathological Co... | RT Dose escalat... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer | NCT02031939 | Advanced Rectal... | Induction chemo... standard chemor... | 18 Years - 75 Years | Sun Yat-sen University | |
Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC | NCT04759235 | Esophageal Squa... | Magnetic resona... 18F-Fluorodeoxy... Blood and urine... | 18 Years - 75 Years | RenJi Hospital | |
Dendrobium Huoshanense Suppository in Rectal Cancer | NCT05079438 | Locally Advance... | Dendrobium Huos... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
Additional Chemotherapy After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer | NCT01671683 | Rectal Cancer | 20 Years - 90 Years | Chungnam National University | ||
RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus | NCT00559351 | Esophageal Neop... Squamous Cell C... | transthoracic e... neoadjuvant che... neoadjuvant che... | 18 Years - 75 Years | Ministry of Scientific Research and Information Technology, Poland | |
Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection | NCT01926483 | Non-small Cell ... | Neoadjuvant Che... | 18 Years - 65 Years | Zhejiang Cancer Hospital | |
Preoperative Anti-PD-1 Antibody Combined With Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus | NCT03792347 | Esophageal Squa... | Pembrolizumab | 18 Years - 75 Years | Ruijin Hospital | |
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC | NCT04973306 | Esophageal Squa... Esophageal Squa... | Neoadjuvant Che... Tislelizumab Ivor-Lewis or M... | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer | NCT01899118 | Locally Advance... | Preoperative ir... Nimotuzumab Oxaliplatin Capecitabine | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer | NCT01815853 | Gastric Cancer | Neoadjuvant Che... Neoadjuvant Che... R0 D2 Gastrecto... Adjuvant Chemot... | 18 Years - 75 Years | Sun Yat-sen University | |
UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal Cancer | NCT03824899 | Locally Advance... | Blood concentra... | 18 Years - 75 Years | Fudan University | |
Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCC | NCT03001596 | Esophageal Squa... | Neoadjuvant Che... Neoadjuvant Che... Minimally Invas... | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction | NCT06250894 | PD-1 Neoadjuvant Che... Gastroesophagea... | PD-1inhibitor | 18 Years - 70 Years | Wuhan Union Hospital, China | |
Prediction of Response to Neoadjuvant Therapy in Rectal Cancer | NCT02439086 | Rectal Neoplasm... | PET-CT Scan | - | Colchester General Hospital | |
Dendrobium Huoshanense Suppository in Rectal Cancer | NCT05079438 | Locally Advance... | Dendrobium Huos... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
Neoadjuvant Chemoradiotherapy vs. Chemotherapy With Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer | NCT01815853 | Gastric Cancer | Neoadjuvant Che... Neoadjuvant Che... R0 D2 Gastrecto... Adjuvant Chemot... | 18 Years - 75 Years | Sun Yat-sen University | |
RadioPathomics Artificial Intelligence Model to Predict Tumor Regression Grading in Locally Advanced Rectal Cancer | NCT04273451 | Rectal Cancer | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | ||
UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer | NCT05148767 | Rectal Cancer S... | Neoadjuvant che... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
Surveillance of Peripheral Blood of Lymphocyte and Immunocyte in Neoadjuvant Therapy Patients With Esophageal Squamous Cell Carcinoma (pLINE) | NCT04440332 | Esophageal Squa... Neoadjuvant The... Surgery | 18 Years - 80 Years | Sichuan Cancer Hospital and Research Institute | ||
Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer | NCT03970694 | Colon Cancer | Radiotherapy oxaliplatin+cap... | 18 Years - 70 Years | Sun Yat-sen University | |
UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer | NCT05148767 | Rectal Cancer S... | Neoadjuvant che... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer | NCT06097416 | Rectal Cancer | Neoadjuvant Che... Total Neoadjuva... | 18 Years - | St. James's Hospital, Ireland | |
Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology | NCT05969938 | Rectal Adenocar... Circulating Tum... Minimal Residua... Neoadjuvant Che... | MRD detection | 18 Years - 75 Years | Sun Yat-sen University | |
Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer | NCT03702985 | Locally Advance... | Radiation Capecitabine Irinotecan Amifostine | 18 Years - 75 Years | Fudan University | |
Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer | NCT02031939 | Advanced Rectal... | Induction chemo... standard chemor... | 18 Years - 75 Years | Sun Yat-sen University | |
Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction or Upper Gastric Adenocarcinoma | NCT02193594 | Gastroesophagea... | Preoperative co... Radical D2 tota... Adjuvant chemot... | 18 Years - 80 Years | Peking University | |
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma(NewEC Study) | NCT04027543 | Radiotherapy Si... Chemotherapy Ef... Oesophageal Car... Effect of Drugs Safety Issues | Neoadjuvant che... Oesophagectomy Neoadjuvant che... | 18 Years - 80 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation Therapy | NCT06099951 | Colorectal Canc... | Serplulimab + F... Radiation thera... | 18 Years - 75 Years | Sun Yat-sen University | |
A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk | NCT04664504 | Rectal Cancer | Concurrent Chem... Short-course Ra... Local dose incr... Consolidation c... Adjuvant chemot... TME | 18 Years - 75 Years | ChineseAMS | |
Dendrobium Huoshanense Suppository in Rectal Cancer | NCT05079438 | Locally Advance... | Dendrobium Huos... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Non-small Cell Lung Cancer | NCT01054482 | Non-small Cell ... | Pre-operative c... Pre-operative c... | 18 Years - 85 Years | The First Affiliated Hospital of Guangzhou Medical University | |
Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer | NCT05601505 | Locally Advance... Circulating Tum... | circulating tum... | 18 Years - 75 Years | Peking Union Medical College Hospital | |
Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer | NCT01463501 | Esophageal Canc... | Neoadjuvant che... Adjuvant chemor... | 18 Years - 65 Years | Zhejiang Cancer Hospital | |
Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCC | NCT03001596 | Esophageal Squa... | Neoadjuvant Che... Neoadjuvant Che... Minimally Invas... | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
Multimodal Functional Imaging Combined With Metabolomics in Predicting the Efficacy of nCRT for Locally Advanced ESCC | NCT04759235 | Esophageal Squa... | Magnetic resona... 18F-Fluorodeoxy... Blood and urine... | 18 Years - 75 Years | RenJi Hospital | |
Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer | NCT06097416 | Rectal Cancer | Neoadjuvant Che... Total Neoadjuva... | 18 Years - | St. James's Hospital, Ireland | |
Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases | NCT01187290 | Non-small Cell ... | neoadjuvant che... | 18 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | |
Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer | NCT04460352 | Esophageal Squa... | Neoadjuvant rad... Carboplatin, pa... Esophagectomy Neoadjuvant rad... Carboplatin, pa... Cisplatin, pacl... Oxaliplatin, ca... Esophagectomy | 18 Years - 80 Years | Karolinska University Hospital | |
Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002) | NCT04807673 | Esophageal Squa... | Pembrolizumab Paclitaxel Cisplatin neoadjuvant che... | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC | NCT04973306 | Esophageal Squa... Esophageal Squa... | Neoadjuvant Che... Tislelizumab Ivor-Lewis or M... | 18 Years - 75 Years | Shanghai Zhongshan Hospital | |
Pre-Surgery If Needed for Oesophageal Cancer | NCT03937362 | Esophageal Canc... | First clinical ... Second clinical... | 20 Years - | Shanghai Chest Hospital | |
Preoperative Chemoradiotherapy Versus Chemotherapy Alone in Nonsmall Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases | NCT01187290 | Non-small Cell ... | neoadjuvant che... | 18 Years - 75 Years | Shanghai Jiao Tong University School of Medicine | |
Prediction of Response to Neoadjuvant Therapy in Rectal Cancer | NCT02439086 | Rectal Neoplasm... | PET-CT Scan | - | Colchester General Hospital | |
Surgery Without Neoadjuvant Chemoradiotherapy Compared With Neoadjuvant Chemoradiotherapy for Rectal Cancer With Negative Circumferential Resection Margin Based on MRI Assessment, a Perspective Multicenter Randomized Controlled Trial | NCT03504449 | Circumferential... Intraoperative ... Local Recurrenc... Disease-free Su... Overal Survival | neoadjuvant che... | 18 Years - 75 Years | Beijing Chao Yang Hospital | |
A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal Cancer | NCT04394598 | Locally Advance... | Dendrobium Huos... Pelvic Radiatio... Capecitabine Irinotecan Placebo | 18 Years - 70 Years | Fudan University | |
Predicting the Efficacy and Prognosis of Rectal Cancer Patients Based on ctDNA-MRD Technology | NCT05969938 | Rectal Adenocar... Circulating Tum... Minimal Residua... Neoadjuvant Che... | MRD detection | 18 Years - 75 Years | Sun Yat-sen University | |
A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal Cancer | NCT04394598 | Locally Advance... | Dendrobium Huos... Pelvic Radiatio... Capecitabine Irinotecan Placebo | 18 Years - 70 Years | Fudan University | |
Outcomes of Resection at Different Times Between the End of Neoadjuvant Treatment and Surgery | NCT04013347 | Neoadjuvant Che... Rectal Tumor Surgery Surgery--Compli... | Rectal Resectio... | 18 Years - 90 Years | Campus Bio-Medico University | |
The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments | NCT03493880 | Gastric Cancer Neoadjuvant Che... Neoadjuvant Che... Systemic Inflam... Nutrition Aspec... | - | Peking University | ||
Neoadjuvant Sintilimab Plus Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction | NCT06250894 | PD-1 Neoadjuvant Che... Gastroesophagea... | PD-1inhibitor | 18 Years - 70 Years | Wuhan Union Hospital, China | |
RadioPathomics Artificial Intelligence Model to Predict nCRT Response in Locally Advanced Rectal Cancer | NCT04271657 | Rectal Cancer | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | ||
RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus | NCT00559351 | Esophageal Neop... Squamous Cell C... | transthoracic e... neoadjuvant che... neoadjuvant che... | 18 Years - 75 Years | Ministry of Scientific Research and Information Technology, Poland | |
Surgery Without Neoadjuvant Chemoradiotherapy Compared With Neoadjuvant Chemoradiotherapy for Rectal Cancer With Negative Circumferential Resection Margin Based on MRI Assessment, a Perspective Multicenter Randomized Controlled Trial | NCT03504449 | Circumferential... Intraoperative ... Local Recurrenc... Disease-free Su... Overal Survival | neoadjuvant che... | 18 Years - 75 Years | Beijing Chao Yang Hospital | |
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma(NewEC Study) | NCT04027543 | Radiotherapy Si... Chemotherapy Ef... Oesophageal Car... Effect of Drugs Safety Issues | Neoadjuvant che... Oesophagectomy Neoadjuvant che... | 18 Years - 80 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
Radiomics-based Artificial Intelligence System to Predict Neoadjuvant Treatment Response in Rectal Cancer | NCT04273477 | Rectal Cancer | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | ||
Neoadjuvant Chemoradiotherapy Versus Neoadjuvant Chemotherapy For Unresectable Locally Advanced Colon Cancer | NCT03970694 | Colon Cancer | Radiotherapy oxaliplatin+cap... | 18 Years - 70 Years | Sun Yat-sen University | |
A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer | NCT04062058 | Gastric Cancer Neoadjuvant The... | SIB-IMRT S-1 SOX Surgery | 18 Years - 75 Years | ChineseAMS | |
Observational Study on the Patients With Rectal Cancer | NCT02312284 | Rectal Cancer Adjuvant Chemor... Neoadjuvant Che... Adjuvant Chemot... Surgery | 18 Years - | ChineseAMS | ||
Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer | NCT01463501 | Esophageal Canc... | Neoadjuvant che... Adjuvant chemor... | 18 Years - 65 Years | Zhejiang Cancer Hospital | |
Modified Sandwich Therapeutic Regimen for Locally Advanced Rectal Cancer | NCT05228431 | Advanced Rectal... | XELOX Capecitabine mo... Radiation | 18 Years - 75 Years | Sun Yat-sen University | |
Pre-Surgery If Needed for Oesophageal Cancer | NCT03937362 | Esophageal Canc... | First clinical ... Second clinical... | 20 Years - | Shanghai Chest Hospital |